Walleye Capital LLC Adaptive Biotechnologies Corp Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $64,684 - $99,644	18,695 New	18,695 $91,000
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $138,771 - $207,049	22,168 New	22,168 $169,000
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $337,085 - $466,500	-10,462 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $389,814 - $708,695	10,462 New	10,462 $421,000
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $371,467 - $540,323	-8,253 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $295,374 - $402,828	8,253 New	8,253 $401,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.